Documents de position
Joint Statement – Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy
Ahead of Friday 18 September's webinar the EU Vaccine Strategy, a number of European and international organisations representing not-for-profit healthcare insurers, healthcare professionals, public i......
AIM launches series of Factsheets on prevention-related issues
AIM has launched a series of factsheets on health promotion and disease prevention related issues. Not only do the documents contain facts and figures on the different themes but also a series of reco......
AIM Recommendations on the Green Paper on Healthy Ageing
AIM welcomes the European Commission’s intention to publish a Green Paper on Healthy Ageing. AIM believes people’s health and well-being should be at the centre of that paper, just as of any EU in......
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe. AIM calls for the European Pharmaceutical Str......
AIM reacts to the publication of the European Pharmaceutical Strategy roadmap
A fair diagnosis but will the treatment match ? The European Commission has published the roadmap to the European Pharmaceutical Strategy. AIM, the leading international umbrella organisation of healt......
EU Collaboration on Vaccination
The current outbreak of COVID-19, its crippling effects on European economies and societies and the race to find a vaccine against the disease have put to the fore the fragility of our societies. It h......